Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

BGM Group Ltd.

BGM•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$1.05
$0.01(0.96%)
U.S. Market opens in 13h 56m

BGM Group Ltd. (BGM) Stock Overview

Explore BGM Group Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap193.6M
P/E Ratio-17.62
EPS (TTM)$-0.29
ROE-0.01%
Fundamental Analysis

AI Price Forecasts

1 Month$1.08
3 Months$0.00
1 Year Target$0.00

BGM Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BGM Group Ltd. (BGM) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 16.83, suggesting the stock is in an oversold condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -17.62 and a market capitalization of 193.6M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.21%
5-Day Change
-7.21%
1-Month Change
-74.06%
3-Month Change
-88.17%
6-Month Change
-87.97%
Year-to-Date (YTD) Change
-73.04%
1-Year Change
-90.33%
3-Year Change
-82.45%
5-Year Change
-82.45%
All-Time (Max) Change
-82.45%

Contact Information

https://www.bgm.ltd
86 28 6477 5180
No. 152 Hongliang East 1st Street, Chengdu, NaN, 610200

Company Facts

2,980 Employees
IPO DateJan 24, 2003
CountryCN
Actively Trading

Frequently Asked Questions